Has the FDA been asked whether it reviewed the cancer studies before it approved the VeriChip?
Yes, this question has been asked on multiple occasions, but as of this writing the agency has refused to provide a direct answer. According to the Associated Press (AP), the FDA declined repeated AP requests to specify what studies it reviewed before approving the VeriChip.43 And in October 2004, this researcher (Katherine Albrecht) filed a Freedom of Information Act (FOIA) request with the FDA asking what documents the agency had reviewed during the approval process. More than a year later, the agency responded with a form letter stating that there were no documents on file matching the request.
Related Questions
- Did the VeriChip Corporation (then operating as "Applied Digital Solutions") intentionally fail to provide the cancer studies to the FDA?
- Is Immunocal approved by the FDA for the treatment of cancer, chronic fatigue, auto-immune, and glutathione deficiency diseases?
- Was the FDA aware of the cancer link when it approved the VeriChip for human use?
